Suneth Agampodi

and 10 more

Objective To estimate the gestational age-specific serum creatinine (sCr) in pregnancy. Design A population-based prospective cohort study. Settings Anuradhapura district, Sri Lanka Population or sample Study group: Healthy pregnant women with a period of gestation less than 12 weeks and without pre-existing medical conditions. Comparison group: A sample of non-pregnant reproductive age females from a population-based renal screening. Methods Baseline data were compared among pregnant and non-pregnant groups and the pregnant women were followed-up until the end of the second trimester. Main Outcome Measures Gestational period-specific sCr. Results A total of 2,259 pregnant women and 2.012 non-pregnant women were recruited. The mean (SD) sCr of the 2,012 nonpregnant women was 62.8(12.4) μmol/L, with the 97.5th percentile of 89.0 μmol/L. The mean (SD) eGFR was 105.1(27.9) mL/min/1.73 m2. At 4-7, 8-9, 10-12, 24-27 and 28-30 weeks of pregnancy, the mean sCr was 55.1, 52.7, 51.0, 47.2, and 49.3, while the 97.5th percentile for sCr was 72.4, 69.2, 69.3, 63.9, and 66.0 μmol/L, respectively, in the sample of pregnant women. In the first and second trimesters, the average sCr value was 84.7% and 76.4% of that of the nonpregnant group, respectively. The mean eGFR increased up to 129.4 mL/min/1.73 m2 in the 24th week of gestation. The analysis of cohort data clearly confirmed a significant reduction in sCr with advancing pregnancy (p<0 .001). Conclusions This study confirms that the precise normative data needs to be considered in the interpretation of sCr in pregnancy, based on the period of gestation.

Iresha Koralagedara

and 4 more

Objective Determine the association of Non-alcoholic fatty liver disease(NAFLD) to the occurrence of GDM and miscarriages. Design Population-based prospective cohort study. Setting Anuradhapura district-Sri Lanka. Sample All pregnant women(gestational age<12 weeks) registered in the national pregnancy care programme(>98%coverage) during July to September-2019, recruited in the Rajarata Pregnancy Cohort(RaPCo)(included 80% of registered mothers). Method Clinical, biochemical parameters and ultrasound scan(USS) of liver were performed at the baseline to assess NAFLD. Excluding pregnant women who reported any type of hyperglycemia at the baseline, the cohort was followed up to assess the occurrence of GDM (using latest WHO criteria) during 24-28 weeks of gestation. Miscarriages were documented. Main outcome measures GDM and miscarriages. Results The prevalence of Fatty liver grade(FLG)-II and I was 14.2%(n=90), 37%(n=234), respectively. The incidence of GDM among the normoglycemic pregnant women with FLG-II, I, and 0 were 162.2, 43.9, 11 per 1000, respectively. After adjusting for age, BMI, and other known risk factors, women with FLG-II had a relative risk(RR) of 12.5(95%CI 2.2-66.4) for developing GDM compared to those with FLG-0. Pregnant women with FLG-I-(RR= 5.1,95%CI-1.7-15.1) and II-(RR=8.4,95%CI-2.6-27.1) had a very high risk of early pregnancy miscarriage compared to FLG-0. Conclusion FLG-2 is a significant risk factor for GDM and miscarriages. Incorporating pre-conceptional or early pregnancy identification of NAFLD using simple USS into routine care provision will enable early risk identification and appropriate action. Funding Accelerating Higher Education Expansion and Development(AHEAD) grant(World Bank-funded project through University grant commission-Sri Lanka) funded this study. Keywords–NAFLD, GDM, Pregnancy, Ultrasound-scan, Miscarriages